BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23913464)

  • 1. Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
    Williams ES; Thompson VP; Chiswell KE; Alexander JH; White HD; Ohman EM; Al-Khatib SM
    Cardiol J; 2013; 20(4):439-46. PubMed ID: 23913464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
    Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.
    De Schryver N; Scavée C; Marchandise S; Pasquet A; de Meester C; le Polain de Waroux JB
    Europace; 2014 Aug; 16(8):1125-30. PubMed ID: 24599938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal dysfunction and atrial fibrillation recurrence following cardioversion.
    Schmidt M; Daccarett M; Rittger H; Marschang H; Holzmann S; Jung P; Bojanic D; Ketteler M; Brachmann J; Rieber J
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1092-8. PubMed ID: 21489032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
    Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
    Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the Cox-maze procedure for atrial fibrillation concomitant to mitral and tricuspid valve surgery.
    Ad N; Holmes SD; Massimiano PS; Pritchard G; Stone LE; Henry L
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1426-34; discussion 1434-5. PubMed ID: 24075462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.
    Nilsson KR; Al-Khatib SM; Zhou Y; Pieper K; White HD; Maggioni AP; Kober L; Granger CB; Lewis EF; McMurray JJ; Califf RM; Velazquez EJ
    Heart; 2010 Jun; 96(11):838-42. PubMed ID: 20406769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.
    Badheka AO; Marzouka GR; Rathod AD; Patel NJ; Myerburg RJ; Mitrani RD
    Am J Cardiol; 2013 Jun; 111(12):1759-63. PubMed ID: 23540545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
    Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
    De Vos CB; Breithardt G; Camm AJ; Dorian P; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Crijns HJ
    Am Heart J; 2012 May; 163(5):887-93. PubMed ID: 22607868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all.
    Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX
    Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
    Curtis AB; Seals AA; Safford RE; Slater W; Tullo NG; Vidaillet H; Wilber DJ; Slee A
    Am Heart J; 2005 Feb; 149(2):304-8. PubMed ID: 15846269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment.
    Cristoni L; Tampieri A; Mucci F; Iannone P; Venturi A; Cavazza M; Lenzi T
    Emerg Med J; 2011 Nov; 28(11):932-7. PubMed ID: 20947916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.
    de Denus S; Sanoski CA; Carlsson J; Opolski G; Spinler SA
    Arch Intern Med; 2005 Feb; 165(3):258-62. PubMed ID: 15710787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set.
    Oto E; Okutucu S; Katircioglu-Öztürk D; Güvenir HA; Karaagaoglu E; Borggrefe M; Breithardt G; Goette A; Ravens U; Steinbeck G; Wegscheider K; Oto A; Kirchhof P
    Europace; 2017 Jun; 19(6):921-928. PubMed ID: 27377074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion.
    Kang JH; Lee DI; Kim S; Kim MN; Park YM; Ban JE; Choi JI; Lim HE; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1165-70. PubMed ID: 22882453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.